Literature DB >> 29270640

[Differential diagnoses of dry eye syndrome and blepharitis].

M C Herwig-Carl1, K U Loeffler2.   

Abstract

Dry eye syndrome and blepharitis are diseases that affect many patients from different age groups. There is not only a great variability in the manifestation between patients but they also show a mixture of associated symptoms. Thus, very different ocular and systemic diseases have to be included in the differential diagnosis of a primary dry eye disorder. This article provides a structured overview of these differential diagnoses and their characteristic appearance as well as the pitfalls and therapeutic options.

Entities:  

Keywords:  Blepharitis; Dry eye syndrome; Inflammatory diseases; Rheumatic diseases; Tumor

Mesh:

Year:  2018        PMID: 29270640     DOI: 10.1007/s00347-017-0631-7

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  23 in total

Review 1.  Update on ocular cicatricial pemphigoid and emerging treatments.

Authors:  Munther M Queisi; Mike Zein; Neerav Lamba; Halea Meese; Charles Stephen Foster
Journal:  Surv Ophthalmol       Date:  2015-12-19       Impact factor: 6.048

2.  [Recurrent keratoconjunctivitis].

Authors:  A Höck; K U Löffler
Journal:  Ophthalmologe       Date:  2016-06       Impact factor: 1.059

3.  Identification of androgen receptor protein and 5alpha-reductase mRNA in human ocular tissues.

Authors:  E M Rocha; L A Wickham; L A da Silveira; K L Krenzer; F S Yu; I Toda; B D Sullivan; D A Sullivan
Journal:  Br J Ophthalmol       Date:  2000-01       Impact factor: 4.638

4.  Dry eye disease in the elderly in a French population-based study (the Montrachet study: Maculopathy, Optic Nerve, nuTRition, neurovAsCular and HEarT diseases): Prevalence and associated factors.

Authors:  Arthur Ferrero; Seydou Alassane; Christine Binquet; Lionel Bretillon; Niyazi Acar; Louis Arnould; Aurore Muselier-Mathieu; Cécile Delcourt; Alain M Bron; Catherine Creuzot-Garcher
Journal:  Ocul Surf       Date:  2017-09-20       Impact factor: 5.033

5.  Sebaceous gland carcinoma of the ocular adnexa - variability in clinical and histological appearance with analysis of immunohistochemical staining patterns.

Authors:  Eva Janine Schmitz; Martina C Herwig-Carl; Frank G Holz; Karin U Loeffler
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-07-24       Impact factor: 3.117

Review 6.  Effects of Sex Hormones on Ocular Surface Epithelia: Lessons Learned From Polycystic Ovary Syndrome.

Authors:  Flavio Mantelli; Costanzo Moretti; Ilaria Macchi; Giacomina Massaro-Giordano; Grazia Maria Cozzupoli; Alessandro Lambiase; Stefano Bonini
Journal:  J Cell Physiol       Date:  2015-11-10       Impact factor: 6.384

7.  Diagnostic relevance of direct immunofluorescence in ocular mucous membrane pemphigoid.

Authors:  Tarun Mehra; Emmanuella Guenova; Frieder Dechent; Florian Würth; Manfred Zierhut; Martin Röcken; Martin Schaller; Christoph Deuter
Journal:  J Dtsch Dermatol Ges       Date:  2015-12       Impact factor: 5.584

Review 8.  [Blepharitis - When to Perform Surgery?].

Authors:  M C Herwig; K U Löffler
Journal:  Klin Monbl Augenheilkd       Date:  2016-07-28       Impact factor: 0.700

9.  Treatment of severe chronic ocular graft-versus-host disease using 100% autologous serum eye drops from a sealed manufacturing system: a retrospective cohort study.

Authors:  Volkan Tahmaz; Uta Gehlsen; Laura Sauerbier; Udo Holtick; Lisa Engel; Stela Radojska; Viorica-Maria Petrescu-Jipa; Christof Scheid; Michael Hallek; Birgit Gathof; Claus Cursiefen; Philipp Steven
Journal:  Br J Ophthalmol       Date:  2016-06-06       Impact factor: 4.638

10.  Keratoconjunctivitis sicca and corneal ulcers.

Authors:  R Hemady; W Chu; C S Foster
Journal:  Cornea       Date:  1990-04       Impact factor: 2.651

View more
  1 in total

1.  [Hordeolum and chalazion : (Differential) diagnosis and treatment].

Authors:  Christiane Loth; Christina V Miller; Christos Haritoglou; Eli Sa Beth M Messmer
Journal:  Ophthalmologe       Date:  2021-08-11       Impact factor: 1.059

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.